Covilife 1.87% (Ivermectin Oral Paste) | Veterinary Antiparasitic Paste

Covilife 1.87% Overview

Covilife 1.87% (Ivermectin Oral Paste) is a veterinary antiparasitic formulation containing 1.87% ivermectin. It is designed to help control susceptible internal and external parasites in approved animal species when used according to the product label and veterinary recommendations.

Ivermectin belongs to the macrocyclic lactone class of antiparasitic medicines. It works by interfering with nerve and muscle function in susceptible parasites, ultimately causing paralysis and elimination. Ivermectin has been used extensively in veterinary parasite management and remains an established active ingredient for several approved animal species.

The oral paste formulation provides a convenient method of administration, while the applicator allows the amount administered to be adjusted according to the animal's body weight and product instructions.

Explore more Ivermectin products: From here

What Is Covilife 1.87% Used For?

Covilife 1.87% may be used as part of a veterinary parasite control program for susceptible parasites in approved animals.

Depending on the animal species and product labeling, ivermectin may help control certain:

• Gastrointestinal roundworms
• Lungworms
• Bots
• Mites
• Other susceptible internal parasites
• Certain susceptible external parasites

The exact parasite coverage depends on the species being treated and the approved labeling for the specific product. Veterinary advice can help determine whether ivermectin is appropriate for a particular parasite or animal.

How Does Ivermectin Work?

Ivermectin affects specific chloride channels found in susceptible parasites. These channels play an important role in regulating nerve and muscle activity.

By altering chloride ion movement, ivermectin disrupts normal nerve signaling within the parasite. This results in paralysis and eventual elimination of susceptible parasites.

The mechanism allows ivermectin to target susceptible parasites at appropriate veterinary doses. However, not all parasites are susceptible to ivermectin, which is why accurate parasite identification and appropriate treatment selection are important.

Key Benefits of Covilife 1.87%

• Contains 1.87% ivermectin
• Veterinary antiparasitic formulation
• Convenient oral paste
• Designed for approved animal species
• Helps control susceptible internal parasites
• May provide activity against certain external parasites
• Easy to administer using an applicator
• Supports routine parasite management
• Established ivermectin formulation
• Useful as part of veterinarian-guided parasite control

Why Choose Covilife Ivermectin Oral Paste?

Effective parasite control is an important part of maintaining animal health. Internal parasites can interfere with nutrient utilization and may contribute to poor body condition, weight loss, digestive problems, reduced performance, and other health concerns.

Covilife 1.87% Ivermectin Oral Paste provides a practical oral formulation for parasite management in approved animals. Its paste format is designed for straightforward administration, while the applicator allows dosing to be adjusted according to the animal's weight and product directions.

A successful parasite control program should also consider environmental exposure, animal age, geographic location, parasite prevalence, previous treatments, and local resistance patterns.

Understanding Parasite Management

Parasites can affect animals in different ways depending on the species involved, the number of parasites present, and the animal's overall health.

Internal parasites may contribute to:

• Weight loss
• Poor body condition
• Digestive disturbances
• Reduced appetite
• Reduced growth
• Lower performance
• General weakness

External parasites may cause irritation, itching, inflammation, and discomfort.

Some animals may carry parasites without displaying obvious symptoms. Regular veterinary examinations and appropriate diagnostic testing can therefore be useful when developing a parasite management program.

Ivermectin and Veterinary Parasite Control

Ivermectin has a long history of veterinary use against susceptible parasites. Its mechanism targets specific nerve and muscle functions that are essential for parasite survival.

However, parasite resistance can affect treatment effectiveness in some populations. Repeated use of the same antiparasitic class without appropriate monitoring may contribute to resistance.

For this reason, veterinarians may recommend targeted treatment, fecal testing, parasite monitoring, and appropriate treatment intervals based on the animal and local parasite risk.

Active Ingredient

Active Ingredient

• Ivermectin 1.87%

Ivermectin provides the antiparasitic activity of Covilife 1.87% Oral Paste.

Other Ingredients

The paste also contains inactive ingredients that help provide the appropriate consistency, stability, and administration characteristics of the formulation. Refer to the product packaging for the complete ingredient list.

How to Use Covilife 1.87% Oral Paste

Use Covilife 1.87% according to the product label and veterinary recommendations.

General administration considerations include:

1. Determine the animal's body weight as accurately as possible.
2. Confirm that the product is approved for the animal species.
3. Set the applicator according to the labeled dosing instructions.
4. Administer the paste orally as directed.
5. Ensure the animal receives the intended amount.
6. Follow the recommended treatment schedule.
7. Store the applicator properly after use.

The appropriate amount depends on body weight, species, parasite risk, and the specific product directions. The 1.87% concentration should not be interpreted as a universal dose for every animal.

Why Accurate Dosing Matters

Accurate dosing is essential when using veterinary antiparasitic medicines. Too little medication may reduce treatment effectiveness, while inappropriate administration can increase the risk of adverse reactions.

Treatment decisions may depend on:

• Animal species
• Body weight
• Age
• Parasite species
• Severity of infestation
• Geographic location
• Previous antiparasitic treatments
• Local resistance patterns

Always use an accurate body weight and follow the specific product label. Consult a veterinarian if you are uncertain about the correct administration.

Integrated Parasite Control

Ivermectin treatment is only one part of effective parasite management. Good husbandry and regular monitoring can help reduce parasite exposure and support animal health.

Depending on the species and environment, useful practices may include:

• Regular veterinary examinations
• Appropriate fecal testing
• Monitoring body condition
• Pasture management
• Proper sanitation
• Cleaning animal housing
• Good nutrition
• Reducing exposure to contaminated environments
• Targeted antiparasitic treatment

A veterinarian can help establish a parasite management plan based on the animal's species, age, environment, and individual risk factors.

Storage Instructions

Store Covilife 1.87% according to the manufacturer's instructions.

• Keep in a cool, dry location.
• Protect from excessive heat and moisture.
• Keep away from direct sunlight.
• Keep the container securely closed.
• Keep out of reach of children and animals not intended for treatment.
• Do not use after the expiration date.

Always refer to the product packaging for specific storage requirements.

Who Can Use Covilife 1.87%?

Covilife 1.87% is intended for approved animal species according to the specific veterinary product labeling.

It may be relevant for:

• Veterinary professionals
• Animal owners
• Equine caretakers
• Farms and livestock operations
• Breeding facilities
• Animal care professionals

Always confirm species suitability before treatment. Veterinary medicines should not automatically be transferred between species without professional guidance.

Possible Side Effects

Ivermectin is generally tolerated when used appropriately, but individual animals can experience adverse reactions.

Possible effects may include:

• Digestive upset
• Diarrhea
• Reduced appetite
• Lethargy
• Other individual reactions

Some reactions may also be associated with parasite death rather than a direct effect of the medicine.

Contact a veterinarian if an animal develops severe, persistent, or unusual symptoms following administration.

Safety Information

Before using Covilife 1.87%:

• Confirm that the product is approved for the animal species.
• Determine body weight accurately.
• Follow the labeled dosage.
• Do not exceed the recommended amount without veterinary advice.
• Consult a veterinarian regarding pregnant, breeding, nursing, very young, elderly, or medically compromised animals.
• Follow applicable withdrawal periods for food-producing animals.
• Avoid accidental exposure to people and animals not intended for treatment.
• Wash hands after handling the product.
• Keep the product safely stored.

Do not use veterinary ivermectin products as substitutes for medicines approved for human use.

Frequently Asked Questions

What is Covilife 1.87%?

Covilife 1.87% is a veterinary ivermectin oral paste containing 1.87% ivermectin for parasite management in approved animal species.

What parasites does ivermectin control?

Ivermectin can control various susceptible internal and external parasites depending on the animal species and product labeling. These may include certain gastrointestinal worms, lungworms, bots, mites, and other susceptible parasites.

How does ivermectin work?

Ivermectin disrupts nerve and muscle function in susceptible parasites by affecting specific chloride channels, ultimately causing paralysis and elimination.

How should Covilife 1.87% be administered?

Administration should follow the product label and veterinary recommendations. The appropriate amount is generally determined using the animal's body weight and the specific dosing instructions for the approved species.

Can Covilife 1.87% be part of a regular parasite control program?

Ivermectin may form part of a veterinary parasite management program when appropriate. Treatment frequency should be based on parasite risk, monitoring, product labeling, and veterinary recommendations.

Can Covilife 1.87% be used in humans?

No. Covilife 1.87% is a veterinary ivermectin oral paste and is not intended for human use. Veterinary formulations should not be substituted for medicines approved for people.

Veterinary Disclaimer

The information provided on this page is for general educational and informational purposes only and is not intended to provide veterinary diagnosis, treatment, or professional advice. Use Covilife 1.87% (Ivermectin Oral Paste) only according to the specific product labeling and appropriate veterinary guidance.

The correct dose, treatment schedule, approved species, parasite coverage, and withdrawal requirements depend on the specific product and animal being treated. Consult a qualified veterinarian before use, particularly for pregnant, breeding, nursing, young, elderly, or medically compromised animals. This veterinary product is not intended for human use.

Final Thoughts

Covilife 1.87% (Ivermectin Oral Paste) provides a convenient veterinary ivermectin formulation for managing susceptible parasites in approved animal species. Its oral paste format makes administration practical, while ivermectin's established antiparasitic mechanism supports control of susceptible parasites when the product is used appropriately.

Responsible parasite management combines accurate dosing with veterinary monitoring, appropriate hygiene, good nutrition, environmental management, and targeted treatment. Always follow the instructions supplied with the specific product and consult a veterinarian when determining whether ivermectin is appropriate for a particular animal or parasite.